Gordon Y J, Cheng K P, Araullo-Cruz T, Romanowski E, Johnson B J, Blough H A
Curr Eye Res. 1986 Feb;5(2):93-9. doi: 10.3109/02713688609015097.
The present study examined the anti-herpetic effect of the glycoprotein inhibitors, hydroxynorvaline and 2-deoxyglucose, alone and in combination with trifluridine on murine ocular herpes. Following ocular inoculation with a large dose of HSV-1 RE strain (10(6) pfu), ICR mice were treated during the acute infection with different therapeutic regimens, and their efficacy was evaluated by ocular virus titers, clinical grading of blepharo-conjunctivitis and histological evaluation of stromal keratitis and iridocyclitis. The results following a large dose HSV-1 inoculum demonstrated that trifluridine was the best single therapeutic agent. Hydroxynorvaline and 2-deoxyglucose had no effect at all. Combination therapy of the glycoprotein inhibitors with trifluridine was no better than trifluridine alone. The mouse HSV-1 keratitis model proved to be an effective, economical alternative to the rabbit model for the evaluation of new antiviral agents.
本研究考察了糖蛋白抑制剂羟基正缬氨酸和2-脱氧葡萄糖单独及与曲氟尿苷联合应用对小鼠眼部疱疹的抗疱疹作用。用大剂量HSV-1 RE株(10⁶ pfu)进行眼部接种后,ICR小鼠在急性感染期接受不同治疗方案治疗,通过眼部病毒滴度、睑结膜炎临床分级以及基质性角膜炎和虹膜睫状体炎的组织学评估来评价其疗效。大剂量接种HSV-1后的结果表明,曲氟尿苷是最佳的单一治疗药物。羟基正缬氨酸和2-脱氧葡萄糖完全没有效果。糖蛋白抑制剂与曲氟尿苷的联合治疗并不比单独使用曲氟尿苷更好。小鼠HSV-1角膜炎模型被证明是一种用于评估新型抗病毒药物的有效、经济的替代兔模型。